-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the 9th, the "Eight Provinces and Two Districts" Joint Procurement Office announced the official selection results of the "Eight Provinces and Two Districts" inter-provincial alliance drug centralized procurement (purchasing number: HLJ-YPDL2021-1), and the plan announced on June 24 The results of the selection are consistent, as follows:
The "Eight Provinces and Two Districts" include Heilongjiang, Shanxi, Inner Mongolia Autonomous Region, Liaoning, Jilin, Sichuan, Tibet, Hainan, Qinghai, and Guizhou.
On April 27, Heilongjiang and other "Eight Provinces and Two Districts" Medical Security Bureau jointly decided to officially announce the launch of the "Eight Provinces and Two Districts" drug centralized procurement work.
On June 24, the "Eight Provinces and Two Districts" Joint Procurement Office released the results of the proposed selection, of which 18 products were selected as the selected enterprises, including mezlocillin sodium injection, clindamycin phosphate injection, fluorouracil injection, lidocaine injection, bone No company won the bid for the oral regular-release dosage form of triol